http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
FDA accepts Cogent's drug application for rare blood disorder treatment
-
Dare Bioscience receives NIH funding extension for preterm birth treatment
-
Merck to present data on cholesterol and heart failure drugs at ACC.26
-
Bitdeer reports 541% jump in February bitcoin production
-
Lightbridge Commends U.S. Department of Energy’s Launch of UPRISE Initiative to Accelerate U.S. Nuclear Energy Expansion
-
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research
-
Ketel One Vodka Gives the Martini its Daytime Debut with Patrick Schwarzenegger in "The Spirit Advisor's Day Off"
-
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value
-
Slate Grocery REIT Announces Distribution for the Month of March 2026
-
Just Women's Sports Brings Fan Activation And Live Podcast Taping To Women's Final Four
-
Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index
-
Bitdeer Announces February 2026 Production and Operations Update
-
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth
-
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
-
Gold Hart Copper Announces Closing of Oversubscribed $18,613,613.72 Financing
-
Palvella receives European patent for QTORIN rapamycin formulation
-
Nasus Pharma reports faster epinephrine delivery in phase 2 study
-
Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin
-
TTGI Provides a Corporate Update Post the Acquisition of Insentra
-
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Thera
-
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update
-
Eledon reports 100% insulin independence in diabetes trial
-
CytomX reports positive phase 1 data for colorectal cancer treatment
-
Floify powers launch of Timberline Mortgage
-
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
-
Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
-
CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
-
Magellan Behavioral Health of Pennsylvania Earns Fourth Consecutive Full Accreditation from the National Committee for Quality Assurance
-
RedChip Highlights Public Companies Advancing the Next Phase of AI Adoption at Virtual Investor Conference on March 19
-
Tank Mix Adjuvants Market worth $2.71 billion by 2031- Exclusive Report by MarketsandMarkets™
-
“One Battle After Another” Wins USA TODAY’s Movie Meter Competition
-
Greenwich LifeSciences begins using commercial GP2 in breast cancer trial
-
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
-
Water-soluble Fertilizers Market worth $31.00 billion by 2031- Exclusive Report by MarketsandMarkets™
-
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
-
POMA AI Achieves Best-in-Class RAG Chunking and Document Ingestion With 77% Token Reduction vs. Conventional Models
-
OCI Global Reports H2 2025 and FY 2025 Unaudited Results
-
New Break Announces Frankfurt Stock Exchange Listing Under the Symbol O91
-
LBank Exchange Listed ZAMIC (Zamica Token)
-
Elubia's Kitchen Brings their Award-Winning "Best Tamale" from the Oxnard Tamale Festival to Isla Vista
-
HII’S Ingalls Shipbuilding Celebrates Apprentice School Graduates
-
VEREM Sets New Benchmark for RWA Security with Successful Completion of Hacken Smart Contract Audit
-
Here Comes the Sun
-
GREEN RAIN ENERGY HOLDINGS, INC. (OTCID: GREH) Green Rain Energy Announces Review of Legacy Convertible Notes and Strengthened Shareholder Protections
-
Numinus Wellness Provides Corporate Update
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Blackstone Mortgage Trust Declares $0.47 Per Share Dividend
-
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
-
BitMart Launches Trading Skills: Transitioning from Code to Intent, Powering the Evolution of Intelligent Trading
-
A4A Statement on TSA's $0 Paychecks
